Kupchyk Areta 4
4 · Anebulo Pharmaceuticals, Inc. · Filed Apr 7, 2025
Insider Transaction Report
Form 4
Kupchyk Areta
Director
Transactions
- Award
Stock Option (right to buy)
2025-04-04+2,647→ 2,647 totalExercise: $1.02Exp: 2035-04-03→ Common Stock (2,647 underlying) - Award
Stock Option (right to buy)
2025-04-04+25,000→ 25,000 totalExercise: $1.02Exp: 2035-04-03→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders.